Utility of antimicrobial susceptibility testing in trichomonas vaginalis-infected women with clinical treatment failure

Sexually Transmitted Diseases

Volumn 38, Issue 10, 2011, Pages 983-987

  Bosserman, Elizabeth A ^a,b   Helms, Donna J ^b   Mosure, Debra J ^b   Secor, W Evan ^b   Workowski, Kimberly A ^b,c  

^a ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURAZOLIDONE; METRONIDAZOLE; PAROMOMYCIN; TINIDAZOLE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; NONHUMAN; RECOMMENDED DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ADOLESCENT; ADULT; AGED; ANTIPROTOZOAL AGENTS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; METRONIDAZOLE; MIDDLE AGED; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; TINIDAZOLE; TREATMENT FAILURE; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UNITED STATES; YOUNG ADULT;

EID: 80052973735     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318224db39     Document Type: Article

References (29)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates 2000. Perspect Sex Reprod Health 2004;36:6-10. (Pubitemid 38258322)
2. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis 1999; 26:S2-S7. (Pubitemid 29177834)
3. Hobbs MM, Sena AC, Swygard H, et al. Trichomonas vaginalis and trichomoniasis. In: Holmes KK, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Disease, 4th ed. New York, NY: McGraw Hill Co, 2008:771-793.
4. Sutton M, Sternberg M, Koumans EH, et al. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis 2007;45:1319-1326. (Pubitemid 351411908)
5. Rughooputh S, Greenwell P. Trichomonas vaginalis: Paradigm of a successful sexually transmitted organism. Br J Biomed Sci 2005;62:193-200. (Pubitemid 41811301)
6. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR 2010;59(RR-12):1-116.
7. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007;195:698-702.
8. Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997;24:353-360. (Pubitemid 27306585)
9. Hager WD, Rapp RP. Metronidazole. Obstet Gynecol North Am 1992;19:497-510.
10. Lamp KC, Freeman CD, Klutman NE, et al. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet 1999;36:353-373. (Pubitemid 29261511)
11. Crowell AL, Sanders-Lewis KA, Secor WE. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother 2003;47:1407-1409. (Pubitemid 36368606)
12. Sobel JD, Nagappan V, Nyirjesy P. Metronidazole-resistant vaginal trichomoniasis-an emerging problem. N Engl J Med 1999; 341:292-293. (Pubitemid 29334535)
13. Forna F, Gülmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003:CD000218.
14. Sawyer PR, Brogden RN, Pinder RM, et al. Tinidazole: A review of its antiprotozoal activity and therapeutic efficacy. Drugs 1976; 11:423-440.
15. Robinson SC. Trichomonal vaginitis resistant to metronidazole. Med Assoc J 1962;86:665.
16. Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006;50:4209-4210. (Pubitemid 44865173)
17. Schmid G, Narcisi E, Mosure D, et al. Prevalence of metronidazole- resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001;46:545-549. (Pubitemid 32592196)
18. Kirkcaldy R, Augostini P, Asbel L, et al. Trichomonas vaginalis in vitro Antibiotic Resistance-STD Surveillance Network, United States, 2009. Presented at the: 48th Meeting of the Infectious Diseases Society of America (IDSA); 2010; Vancouver, Canada.
19. Yu H, Tak-Yin M. The efficacy of povidone-iodine pessaries in a short, low-dose treatment regime on candidal, trichomonal and nonspecific vaginitis. Postgrad Med J 1993;69(suppl 3):S58-S61. (Pubitemid 23317406)
20. Porapakkham S. Metronidazole treatment of vaginal trichomoniasis. II: Oral versus vaginal therapy. Obstet Gynecol 1967;29: 213-216.
21. Helms DJ, Mosure DJ, Secor WE, et al. Management of Trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol 2008;198:370E1-370E7.
22. Nyirjesy P, Sobel JD, Weitz MV, et al. Difficult-to-treat trichomoniasis: Results with paromomycin cream. Clin Infect Dis 1998;26:986-988. (Pubitemid 28180342)
23. Mammen-Tobin A, Wilson JD. Management of metronidazoleresistant Trichomonas vaginalis: A new approach. Int J STD AIDS 2005;16:488-490. (Pubitemid 41003150)
24. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001;33: 1341-1346. (Pubitemid 32955184)
25. Bosserman EA, Helms DJ, Mosure DJ, et al. Treatment of women with metronidazole-resistant Trichomonas vaginalis infections. Presented at the: International Society for Sexually Transmitted Disease Research (ISSTDR) Conference; 2007; Seattle, WA.
26. Gillette H, Schmid GP, Mosure D, et al. Metronidazole-resistant Trichomonas vaginalis, a case series, 1985-1998. Presented at the: 13th Meeting of the International Society of Sexually Transmitted Disease Research; 1999; Denver, CO.
27. Gelbart SM, Thomason JL, Osypowski PJ, et al. Growth of Trichomonas vaginalis in commercial culture media. J Clin Microbiol 1990;28:962-964. (Pubitemid 20141208)
28. Meingassner JG, Thurner J. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother 1979;15:254-257. (Pubitemid 9094768)
29. Lossick JG, Muller M, Gorrell TE. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis 1986;153:948-955. (Pubitemid 16114873)